Janssen, Antwerpseweg 15-17, 2340, Beerse, Belgium.
BMC Psychiatry. 2013 Feb 17;13:58. doi: 10.1186/1471-244X-13-58.
Discontinuation of antipsychotic treatment for schizophrenia can interrupt improvement and exacerbate the illness. Reasons for discontinuing treatment are multifactorial and include adherence, efficacy and tolerability issues. Poor adherence may be addressed through non-pharmacological approaches as well as through pharmacological ones, ie ensured delivery of medication, such as that achieved with long-acting injectable (LAI) antipsychotics. However, attitudes of healthcare professionals (HCPs) towards LAI antipsychotics may influence their prescribing decisions and may influence medication choices offered to patients. We therefore conducted a survey to investigate factors driving LAI use as well as physician and nurse attitudes to LAI antipsychotics and to different injection sites.
An independent market research agency conducted the survey of HCPs across Europe. Participants were recruited by telephone and completed the survey online. Using conjoint analyses (a multivariate statistical technique analysing preferences on the basis of ranking a limited number of attributes which are presented repetitively), attitudes to oral versus LAI medication and gluteal versus deltoid injection routes were assessed.
A total of 891 HCPs across Europe were surveyed. Of these, 40% would choose LAI antipsychotics for first episode patients whereas 90% would select LAI antipsychotics for chronic patients with two to five psychotic episodes. Dominant elements in antipsychotic choice were low sedation but no tardive dyskinesia, no or mild pain at injection and low risk of embarrassment or impact upon therapeutic alliance. Eighty-six per cent of respondents considered that having the choice of a deltoid as well as gluteal administration site was beneficial over not having that choice. Two thirds of respondents said they agreed that medication administration via the deltoid muscle may reduce social embarrassment associated with LAI antipsychotics and most respondents (61%) believed that administration of LAI antipsychotics into the deltoid muscle as opposed to the gluteal muscle may be more respectful to the patient.
In this survey of physicians and nurses, attitudes towards LAI antipsychotics compared with oral medication were generally positive. Respondents considered that the availability of a deltoid administration route would offer increased choice in LAI antipsychotic administration and may be perceived as more respectful and less socially embarrassing.
精神分裂症的抗精神病药物治疗中断会中断改善并加重病情。停止治疗的原因是多方面的,包括依从性、疗效和耐受性问题。通过非药物和药物方法可以解决依从性差的问题,例如确保药物的输送,如长效注射(LAI)抗精神病药物所实现的。然而,医疗保健专业人员(HCP)对 LAI 抗精神病药物的态度可能会影响他们的处方决策,并可能影响向患者提供的药物选择。因此,我们进行了一项调查,以调查推动 LAI 使用的因素,以及医生和护士对 LAI 抗精神病药物以及不同注射部位的态度。
一家独立的市场研究机构对欧洲的 HCP 进行了调查。通过电话招募参与者,并在线完成调查。使用联合分析(一种多变量统计技术,根据对有限数量的属性的排序来分析偏好,这些属性会重复呈现)评估了口服药物与 LAI 药物以及臀肌与三角肌注射途径的态度。
在欧洲共调查了 891 名 HCP。其中,40%的人会选择 LAI 抗精神病药用于首发患者,而 90%的人会选择 LAI 抗精神病药用于有 2-5 次精神病发作的慢性患者。抗精神病药物选择的主要因素是低镇静作用但无迟发性运动障碍、注射时无或轻度疼痛以及低尴尬风险或对治疗联盟的影响。86%的受访者认为,有选择三角肌和臀肌注射部位的选择比没有这种选择更有益。三分之二的受访者表示同意,通过三角肌肌肉给药可能会减少与 LAI 抗精神病药物相关的社会尴尬,大多数受访者(61%)认为将 LAI 抗精神病药物注射到三角肌而不是臀肌可能更尊重患者。
在这项对医生和护士的调查中,与口服药物相比,他们对 LAI 抗精神病药物的态度普遍较为积极。受访者认为,提供三角肌注射途径将增加 LAI 抗精神病药物的给药选择,并可能被视为更受尊重且不那么尴尬。